Tomáš Skála (Kardi AI)
Overview
Tomáš Skála is a prominent figure in the field of health technology, notably for his role as co-founder of Kardi AI, a Czech HealthTech startup. He is renowned for his expertise in cardiology and cardiac electrophysiology. Kardi AI, established in 2022, aims to revolutionize cardiac care using advanced artificial intelligence (AI) technology to provide continuous and affordable ECG monitoring. The company, under Skála’s leadership, has quickly gained attention for its innovative approach to heart health, integrating wearable technology with AI to offer real-time health insights.
Recent Developments
Over the past few years, Tomáš Skála and Kardi AI have made significant strides in the HealthTech industry, marked by notable developments:
- April 2025: Kardi AI successfully closed a new €1.1 million investment round. Vlastimil Hrabal was appointed as the new CEO, with plans for international expansion into markets such as Poland, Slovakia, Bulgaria, Romania, the UAE, and India.
- November 2023: Kardi AI secured €1.5 million from European investors to enhance its product’s market reach and technological development. The funding round was aimed at expanding their presence beyond the Czech Republic.
- 2023: By the end of 2023, Kardi AI's services were utilized by over 600 users and collaborated with more than 70 cardiologists and neurologists. The company processed over 250 million heartbeats and identified arrhythmias in 23% of users, highlighting the effectiveness of its AI-driven monitoring.
- 2023: Kardi AI was recognized as one of the top 50 global projects by the Health Tech World association and was a finalist in the MedTech competition, underscoring its impact in digital health innovation.
Personal Information
| Attribute | Information |
|---|---|
| Full Name | Prof. Tomáš Skála |
| Born | |
| Nationality | Czech |
| Occupation | Cardiologist, HealthTech Entrepreneur |
| Known For | Co-founding Kardi AI, Cardiac Electrophysiology |
| Education | Faculty of Medicine, Palacký University in Olomouc |
Early Life and Education
Tomáš Skála graduated from the Faculty of Medicine at the Palacký University in Olomouc, where he cultivated a profound interest in cardiology and medical research. He remained affiliated with his alma mater, advancing to lead the Department of Cardiac Electrophysiology at the university hospital. Skála’s expertise spans the catheterization treatment of complex heart rhythm disorders and the development of new methods of ECG monitoring. His deep background in medical research and his involvement in numerous foreign internships in Western Europe and overseas have equipped him with the insight and innovative approach necessary to co-found Kardi AI.
Career and Notable Achievements
Tomáš Skála’s career is distinguished by his contributions to cardiology and his entrepreneurial venture with Kardi AI:
- Founder of Kardi AI: Skála co-founded Kardi AI in 2022 alongside Stephen Burke and Pavel Digaňa, with the goal of leveraging AI technology to improve cardiac monitoring and patient care.
- Cardiac Electrophysiologist: He heads the Department of Cardiac Electrophysiology at the University Hospital in Olomouc, where he focuses on advanced treatments and research.
- HealthTech Innovations: Under his guidance, Kardi AI developed a wearable device paired with an AI-driven app to provide real-time monitoring of cardiac health, which has detected critical arrhythmias in numerous users and impacted patient outcomes.
Current Work and Impact
Currently, Tomáš Skála continues to drive innovation in cardiac care through Kardi AI. The startup's continuous growth and international expansion plans seek to transform heart health monitoring and preventive care on a global scale. With its AI-enhanced technology, Kardi AI aims to reduce the burden on traditional cardiac monitoring systems and enhance early detection capabilities which are crucial in managing cardiac health effectively.
Conclusion
Tomáš Skála’s contributions to the field of cardiology and digital health through Kardi AI have marked a significant step forward in cardiac care. His innovative use of AI to transform heart health monitoring exemplifies the potential of technology to improve health outcomes. As Kardi AI continues its expansion into international markets, Skála's vision for affordable, accessible cardiac care positions the company as a leader in the HealthTech sector, with the potential to save lives and shape the future of digital healthcare.